FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new compounds described by general formulas specified below, in the free form as pharmaceutically acceptable salts possessing anticancer activity and may be applicable in medical practice as a therapeutic agent for treating cancer. The compounds under the present invention are described by one of structure formulas: 
or 
wherein Ar represents Ph or 4-NO2-C6H4.
EFFECT: presented compounds enable reducing or eliminating completely tumour cell growth by disturbing cell division at the level of enzyme inhibition.
1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PRODRUG FOR THERAPY OF TUMORS AND INFLAMMATORY DISEASES | 1997 |
|
RU2191021C2 |
| EGFR INHIBITOR COMPOUNDS | 2017 |
|
RU2751341C2 |
| SUBSTANCE WITH ANTIVIRAL AND ANTIBACTERIAL ACTIVITY BASED ON DERIVATIVES OF 2,8-DITHIOXO-1H-PYRANO[2,3-D; 6,5-D']DIPYRIMIDINE AND THEIR 10-AZA-ANALOGUES | 2003 |
|
RU2246496C1 |
| PYRAZOLOPYRIMIDONE OR PYRROLOTRIAZONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATIONS THEREOF | 2014 |
|
RU2674977C2 |
| SUBSTITUTED N2-(4-AMINO-2-METHOXYPHENYL)-N4-[2-(DIMETHYLPHOSPHORYL)-PHENYL]-5-CHLORO-PYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, APPLICABLE FOR TREATING CANCER | 2015 |
|
RU2607371C1 |
| DERIVATIVES OF 1-AZIRIDINO-1-HYDROXYIMINOMETHYL, METHOD FOR THEIR PREPARING AND MEDICINAL PREPARATIONS COMPRISING THESE COMPOUNDS | 2000 |
|
RU2264397C2 |
| ANTINEOPLASTIC AGENT | 2016 |
|
RU2623034C1 |
| PYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1998 |
|
RU2199531C2 |
| COMPOUNDS FOR TREATING CANCER | 2010 |
|
RU2581367C2 |
| INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR | 2013 |
|
RU2679130C2 |
